Skip to main content
logo
Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
23.24
-1.21 (-4.95%)
At close: Oct 2, 2026, 4:00 PM EDT
23.00
-0.24 (-1.02%)
After-hours: Oct 2, 2026, 7:44 PM EDT

Tango Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,9191,1933321,010639958
Market Cap Growth
341.62%259.50%-67.13%57.94%-33.25%-
Enterprise Value
2,9371,07576689287461
Last Close Price
23.248.863.099.907.2510.94

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
72.8219.137.8927.6425.7225.86
PB Ratio
3.823.451.663.992.562.78
P/TBV Ratio
3.823.451.663.992.562.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
54.5717.241.8118.8711.5312.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.100.180.150.170.00
Net Debt / Equity Ratio
-0.96-0.89-1.11-1.18-1.30-1.40
Net Debt / EBITDA Ratio
7.312.841.552.672.978.44
Net Debt / FCF Ratio
6.812.211.672.492.787.88
Asset Turnover
0.080.170.120.090.050.11
Quick Ratio
49.9515.836.767.336.6311.98
Current Ratio
50.8216.326.987.546.7612.10
Return on Equity (ROE)
-21.34%-37.23%-57.58%-40.49%-36.41%-30.38%
Return on Assets (ROA)
-12.99%-19.45%-25.31%-17.01%-14.82%-10.28%
Return on Capital Employed (ROCE)
-12.90%-29.50%-52.30%-32.00%-29.20%-12.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.16%-8.51%-39.26%-10.08%-16.92%-6.08%
FCF Yield
-3.68%-11.73%-39.85%-11.84%-18.27%-6.41%
Buyback Yield / Dilution
-22.81%-6.35%-15.50%-7.69%-41.40%-94.50%
SEC Filings: 10-K · 10-Q